Microdiag Biomedical Technology Co., Ltd. was founded in 2008.9.9, located in the national nano high-tech industrialization base - Suzhou Nano City. It is a company focusing on cancer, Alzheimer's, acute infectious diseases and other major diseases. Monitoring is the entry point, focusing on innovative national high-tech enterprises that combine new markers/key technology raw materials/automatic instruments.

At present, there are 3 R&D and production companies, 3 medical testing laboratories, and 3 marketing companies for Zhenbi. The headquarters has a standardized molecular medicine laboratory of 2500 square meters, a class III in vitro diagnostic kit production workshop of 1500 square meters and a class II medical device production workshop of 3000 square meters. In April 2010, it obtained the production of class III in vitro diagnostic reagents and class II medical devices. License. Shanghai Liangrun Biomedical Technology Co., Ltd. has an 800-square-meter scientific research laboratory, a 2,000-square-meter GMP standard workshop, and has obtained the EU ISO13485 certification. It has developed a number of pioneering products and has an annual production capacity of 50 million reagents. Anhui Weizhen Bioengineering Technology Co., Ltd. is mainly engaged in the research and development of diagnostic instruments and supporting consumables. At present, it has successfully developed the world's first fully automatic methylation pretreatment equipment NEW-24, which is about to be independently developed for clinical trials. Particle chemiluminescence POCT equipment, nucleic acid rapid detection products, etc.

The three clinical testing subsidiaries, namely Kuike, Dowell, and Premed, mainly rely on the Microdiag technology and products to create a unique third-party independent medical clinical testing center.